Ligand Pharmaceuticals | Pasivo Circulante



Current Liabilities Cambio Fecha
Amgen USD 23.01B 91M 2025-03
Arrowhead Research USD 220.54M 126.78M 2025-03
Baxter International USD 6.51B 311M 2024-12
Bristol-Myers Squibb USD 24.07B 296M 2025-03
Eli Lilly USD 30.07B 1.69B 2025-03
Gilead Sciences USD 12B 279M 2024-12
GlaxoSmithKline GBP 20.83B 866M 2025-03
Glaxosmithkline GBP 21.7B 238M 2024-12
Insmed USD 239.23M 58.29M 2025-03
Ionis Pharmaceuticals USD 250.29M 59.02M 2025-03
Ligand Pharmaceuticals USD 58.68M 21.57M 2025-03
MacroGenics USD 55.53M 3.78M 2024-12
Merck USD 25.17B 3.25B 2025-03
Pacira USD 314.73M 4.81M 2025-03
Pfizer USD 36.45B 6.54B 2025-03
Veracyte USD 78.63M 8.32M 2024-12



Ligand Pharmaceuticals Pasivo Circulante - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.